Quantum-Si is building a lab instrument that can read proteins one by one, so diseases can be caught earlier. DNA reading grew into a giant industry in twenty years; this company wants to repeat that story with protein reading. They are still early in the journey.
The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.
That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.
Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Clearly below the class average.
Clearly below the class average.
Clearly below the class average.
Clearly below the class average.
Clearly below the class average.
Valuation: The stock trades at a price that looks expensive next to its earnings; that can cap future returns.
Business Quality: Profit power and business quality trail similar companies in the sector.
angles, checked one by one.
The 3 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Profit per Sale: Right now the product sells for less than it costs to make; every sale deepens the loss.
An investor who bought at the very peak is down 92% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
Sales run at $2.4M a year. A small number, but proof the product has real buyers.
There is $162.9M in the vault; even if every debt were paid off, $158.7M would remain.
It met or beat analyst expectations in 7 of the last 8 quarters — consistency is a promise kept.
A loss of $101.3M against $2.4M in annual sales. And on top of that, sales fell from the year before.
The stock sits at $0.84. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.
This stock swings about 3.3 times as much as the market average. Big rallies — and big drops — can both happen fast.
On our five-subject report card, QSI sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: QSI is a high-risk stock — not yet profitable, and its future rides on its product catching on.
Analysts’ average target sits above today’s price, yet the valuation grade (10/100) says the stock isn’t cheap.